Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
weight loss, Suicidal ideation
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
Medicare coverage of weight loss drugs would cost $35B: CBO
Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the Congressional Budget Office (CBO). In its estimates released Tuesday, CBO
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Ozempic Weight Loss Users at Risk of Gastroparesis and Other Stomach Problems, New Study Reveals
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs Ozempic (semaglutide)
Study: Obese teens taking popular weight loss drugs less likely to consider suicide
Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.
GLP-1 medications, their effect on bariatrics and cautions for people seeking weight loss without surgery
Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their success in managing blood sugar levels and drastically reducing weight. Between new clinical trial results and a boom in celebrity usage, the popularity of the medications increased drastically over the past two years.
GLP-1 Weight-Loss Meds Won't Raise Teens' Suicide Risk, May Even Lower It
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts. But a new study involving more than 54,
Omaha.com
4d
1 in 10 Americans have tried injectable weight loss medication—These are the cities with the most early adopters
In tandem, public perceptions of these
medications
are evolving significantly. With celebrities crediting the
new
...
3h
on MSN
Impact of medical weight loss on kidney disease
In a recent study explained in Medical News Today, weight loss surgery can significantly decrease the progression of kidney ...
2d
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...
clickondetroit.com
4d
Low insurance coverage hampers access to weight-loss medications
In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...
5d
Health plans at 1 in 5 large companies cover weight-loss drugs for employees
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...
Wyoming News
5d
Only 1 in 5 Large Companies' Health Plans Cover New Weight-Loss Meds for Employees
When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback